1. Home
  2. ILMN vs GIB Comparison

ILMN vs GIB Comparison

Compare ILMN & GIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • GIB
  • Stock Information
  • Founded
  • ILMN 1998
  • GIB 1976
  • Country
  • ILMN United States
  • GIB Canada
  • Employees
  • ILMN N/A
  • GIB N/A
  • Industry
  • ILMN Medical Specialities
  • GIB Professional Services
  • Sector
  • ILMN Health Care
  • GIB Consumer Discretionary
  • Exchange
  • ILMN Nasdaq
  • GIB Nasdaq
  • Market Cap
  • ILMN 23.6B
  • GIB 25.5B
  • IPO Year
  • ILMN 2000
  • GIB N/A
  • Fundamental
  • Price
  • ILMN $134.96
  • GIB $110.33
  • Analyst Decision
  • ILMN Buy
  • GIB Buy
  • Analyst Count
  • ILMN 17
  • GIB 3
  • Target Price
  • ILMN $163.12
  • GIB $136.67
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • GIB 151.7K
  • Earning Date
  • ILMN 02-06-2025
  • GIB 01-29-2025
  • Dividend Yield
  • ILMN N/A
  • GIB N/A
  • EPS Growth
  • ILMN N/A
  • GIB 6.56
  • EPS
  • ILMN N/A
  • GIB 5.41
  • Revenue
  • ILMN $4,390,000,000.00
  • GIB $10,863,578,959.00
  • Revenue This Year
  • ILMN N/A
  • GIB $8.01
  • Revenue Next Year
  • ILMN $4.05
  • GIB $4.21
  • P/E Ratio
  • ILMN N/A
  • GIB $20.39
  • Revenue Growth
  • ILMN N/A
  • GIB 2.66
  • 52 Week Low
  • ILMN $97.36
  • GIB $96.92
  • 52 Week High
  • ILMN $156.66
  • GIB $118.89
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 40.09
  • GIB 46.34
  • Support Level
  • ILMN $130.31
  • GIB $106.34
  • Resistance Level
  • ILMN $137.69
  • GIB $110.27
  • Average True Range (ATR)
  • ILMN 5.13
  • GIB 1.69
  • MACD
  • ILMN -1.03
  • GIB -0.20
  • Stochastic Oscillator
  • ILMN 21.69
  • GIB 46.34

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company generates more than CAD 14 billion in annual revenue, employs over 90,000 personnel, and operates across 400 offices in 40 countries. CGI offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services. Its largest vertical market is government, which contributes more than a third of group revenue.

Share on Social Networks: